Vincent Leroy

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

Pierre Nahon, Valérie Bourcier, Richard Layese et al. · Gastroenterology · 2016 · 530 citations

Hepatology, Hepatitis C, Viral Hepatitis +8

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)

Marc Bourlière, Jean-Pierre Bronowicki, Victor de Lédinghen et al. · The Lancet Infectious Diseases · 2015 · 280 citations

Hepatology, Viral Hepatitis, Antiviral Drug Development +9

Circulating Matrix Metalloproteinases 1, 2, 9 and Their Inhibitors TIMP-1 and TIMP-2 as Serum Markers of Liver Fibrosis in Patients With Chronic Hepatitis C: Comparison With PIIINP and Hyaluronic Acid

Vincent Leroy, Frédérique Monier, Serge P. Bottari et al. · The American Journal of Gastroenterology · 2004 · 255 citations

Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience

Audrey Coilly, Bruno Roche, Jérôme Dumortier et al. · Journal of Hepatology · 2013 · 196 citations

Protease Inhibitors, Hepatology, Hepatitis C +9

Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: A large multicentre audit with real-life results

Dominique Thabut, Arnaud Pauwels, Nicolas Carbonell et al. · Journal of Hepatology · 2017 · 124 citations

Cirrhotic Patients, Hepatology, Portal Hypertension +8